View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Kinepolis: June 2025 Box office revenue/ attendance in US/Canada and France down. Utilities – Offshore Wind: Big Not So Beautiful Bill

Research Team
  • Research Team

The Rear-View Mirror – EME markets: rebound in Türkiye

EME Equity Market – June 2025 All EME indices in the green in June, with a rebound in Türkiye. The MSCI EM Europe Index advanced by 3.2% mom in EUR terms and 6.9% in USD terms. The Turkish ISE 30 Index was the best performer in our region, recouping the losses from the previous month and adding +6.6% mom in EUR terms. The Hungarian BUX and the Polish WIG indices added 3.1% and 2.8% mom in EUR terms, respectively, followed closely by the Romanian BET and the Greek ASE, with both adding 2.0% mom i...

BRE MBANK SA
EUROB EUROBANK ERGASIAS SERVICES & HOLDINGS SA
PEO BANK POLSKA KASA OPIEKI SA
OPAP GREEK ORGANISATION OF FOOTBALL PROGNOSTICS SA
EXAE HELLENIC EXCHANGES SA
MOL MOL NYRT
CEZ CEZ AS
CDR CD PROJEKT S.A.
OMV OMV AG
TITK TITAN CEMENT CO. SA
WIZZ WIZZ AIR HOLDINGS PLC
PZU POWSZECHNY ZAKLAD UBEZPIECZEN SPOLKA AKCYJNA
SPL SANTANDER BANK POLSKA SA
GEKTERNA GEK TERNA
KTY GRUPA KETY SA
DOC DO & CO AKTIENGESELLSCHAFT
TPS ORANGE POLSKA S.A.
MYTIL MYTILINEOS S.A.
LPP LPP S.A.
BRISA BRISA-BRIDGESTONE SABANCI LASTIK SANAYI VE TICARET A.S.
CCC CCC SA
CCOLA COCA-COLA ICECEK A.S.
2310 SAHARA INTERNATIONAL PETROCHEMICAL COMPANY
DOM DOM DEVELOPMENT SA
AEGN AEGEAN AIRLINES SA
PGE PGE POLSKA GRUPA ENERGETYCZNA S.A.
PGSUS.E PEGASUS HAVA TASIMACILIGI AS
APR AUTO PARTNER SA
LVC LIVECHAT SOFTWARE SA
TPEIR PIRAEUS BANK SA
ALPHA ALPHA BANK AE
PPC PUBLIC POWER CORPORATION S.A.
CAR INTER CARS S.A.
ARCLK ARCELIK A.S.
THYAO TURK HAVA YOLLARI A.O.
MBR MO-BRUK S.A.
GPW WARSAW STOCK EXCHANGE
11B 11 BIT STUDIOS S.A.
BELA JUMBO S.A.
BRD BRD-GROUPE SOCIETE GENERALE
TLV BANCA TRANSILVANIA S.A.
SNP PETROM S.A.
PBK PATRIA BANK SA
DNP DINO POLSKA S.A.
NBGGY NATIONAL BANK OF GREECE S.A. ADS
RICHT RICHTER
MAVI MAVI GIYIM SANAYI VE TICARET A.S.
R22 R22
MCOV B MEDICOVER AB
CGEO GEORGIA CAPITAL
TEN TEN SQUARE GAMES
CZG CESKA ZBROJOVKA GROUP
DUNAHOUSE DUNA HOUSE
INPST INPOST S.A.
HUGE HUUUGE
4IG 4IG NYRT
VRC VERCOM SA
ADNOCDRILL ADNOC DRILLING CO
2381 ARABIAN DRILLING CO.
SHO SHOPER SA
ACAG AUSTRIACARD HOLDINGS AG
BOROUGE BOROUGE
MUR2 MURAPOL SA
THEON THEON INTERNATIONAL PLC
GEV GEVORKYAN A.S.
 PRESS RELEASE

Informations relatives au nombre total de droits de vote et d’actions ...

Informations relatives au nombre total de droits de vote et d’actions composant le capital Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 2 juillet 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), société intégrée de biotechnologie qui développe des immunothérapies innovantes, en direct ou via des partenariats, pour l’activation et la régulation immunitaire en immuno-oncologie et en immuno-inflammation, i...

 PRESS RELEASE

OSE Immunotherapeutics met à jour l’information sur les procédures en ...

OSE Immunotherapeutics met à jour l’information sur les procédures en cours OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that following the hearing on June 24th, 2025, the President of the Nantes Commercial Court rejected, pursuant to an order dated July 1, 2025, the motions brought by the group of shareholders acting in concert, seeking the retraction of the order of June 10, 2025, authorizing the adjournment of the OSE’s annual general meeting1. Furthermore, as c...

 PRESS RELEASE

OSE Immunotherapeutics met à jour l’information sur les procédures en ...

OSE Immunotherapeutics met à jour l’information sur les procédures en cours OSE Immunotherapeutics met à jour l’information sur les procédures en cours NANTES, France, 2 juillet 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) annonce qu’à la suite de l’audience du mardi 24 juin 2025, le Président du Tribunal de Commerce de Nantes a rejeté, par ordonnance en date du 1er juillet 2025, les demandes formées par le groupe d’actionnaires concertistes visant à la rétractation de l’ordonnance du 10 juin 2025 ayant autorisé l’ajournement de l’assemblée générale annuell...

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Livio Luyten
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update July: Removing Fagron and Melexis, Adding...

Since the last publication of our Dynamic Top Pick List on 5 June 2025, our selection has seen again a nice outperformance versus the reverence indices (AEX, Bel20 and Eurostoxx50) of on average 3.3%. Our July update brings 3 adjustments to the list : Since being added to the list in December 2024, Fagron's share price has surged +/-22%, driven by strong Q1 2025 results and robust growth across all regions. Fagron reaffirmed its FY25 guidance and unveiled its “Compounding for Growth” strategy, ...

Delphine Brault ... (+2)
  • Delphine Brault
  • Steven Boumans
Delphine Brault ... (+2)
  • Delphine Brault
  • Steven Boumans
 PRESS RELEASE

OSE Immunotherapeutics Publishes Letter to Shareholders

OSE Immunotherapeutics Publishes Letter to Shareholders OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to Shareholders. The Company’s CEO and Board of Directors wish to share with shareholders the key achievements of recent months, the foundations of its growth strategy and perspectives for the future. The Letter to Shareholders is available on the Company's website: . ABOUT OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics is...

 PRESS RELEASE

OSE Immunotherapeutics publie une Lettre aux Actionnaires

OSE Immunotherapeutics publie une Lettre aux Actionnaires OSE Immunotherapeutics publie une Lettre aux Actionnaires NANTES, France, 30 juin 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce la publication de sa première Lettre aux Actionnaires. Le Directeur général et le Conseil d’administration de la Société souhaitent partager avec les actionnaires les réalisations clés des derniers mois, les perspectives à venir et les fondements de sa stratégie de croissance. La Lettre aux Actionnaires est disponible sur le site internet de la Société : . À PRO...

 PRESS RELEASE

2025 Combined General Meeting Minutes

2025 Combined General Meeting Minutes PRESS RELEASENantes, June 26, 2025 COMBINED GENERAL MEETING OF 26 JUNE 2025 All resolutions adopted by a very large majority John Browett, appointed Independent Director, elected Chairman of the Board of Directors The Combined General Meeting of Maisons du Monde shareholders convened on June 26, 2025, chaired by Françoise Gri and attended by members of the Board of Directors and the statutory auditors. The quorum for the General Meeting was 76.08%. Shareholders adopted by a very large majority all resolutions submitted for their vote, including: ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch